Opis działalności
The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Zarząd & Rada nadzorcza
| CEO |
| Dr. Wolfgang Wienand |
| Zarząd |
| Dr. Reto Suter, Dr. Jürgen Roos, Irene Wosgien, Marcel Imwinkelried, Marianne Späne, Henrik Krüpper, Christian Dowdeswell |
| Rada nadzorcza |
| Dr. Andreas Casutt, Alexandra Brand, Beat Walti, Dr. Martin Schmid, Isabelle Welton, Wolfram Carius, Elodie Carr-Cingari |
Dane firmy
| Nazwa: |
Siegfried Holding AG |
| Adres: |
Untere Brühlstraße 4,CH-4800 Zofingen |
| Telefon: |
+41-62-746-1111 |
| Fax: |
+41-62-746-1202 |
| E-mail: |
info@siegfried.ch
|
| Internet: |
www.siegfried.ch |
| Przemysł: |
Surowce naturalne |
| Sektor: |
Chemia |
| Podsektor: |
- |
| Koniec roku finansowego: |
31.12 |
| Free float: |
75,10% |
| Data IPO: |
- |
